Citation Impact
Citing Papers
Mammalian Transient Receptor Potential TRPA1 Channels: From Structure to Disease
2019
Caloric restriction leads to high marrow adiposity and low bone mass in growing mice
2010
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation
2012
Adverse Health Effects of Marijuana Use
2014 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Marine natural products
1990 Standout
Irritant-evoked activation and calcium modulation of the TRPA1 receptor
2020 StandoutNatureNobel
New approaches and challenges to targeting the endocannabinoid system
2018
Cannabis sativa: The Plant of the Thousand and One Molecules
2016
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
2013
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire
2009
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
2015
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
2014
Phytochemistry of Cannabis sativa L.
2017 Standout
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
2012
What We Talk About When We Talk About Fat
2014 Standout
Hemp (Cannabis sativa L.)
2014
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
2012
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
2010
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Cannabinoids and the expanded endocannabinoid system in neurological disorders
2019
Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism
2013
Molecular mechanism of TRPV2 channel modulation by cannabidiol
2019
Modulation of Thermoreceptor TRPM8 by Cooling Compounds
2012
Leucettamols, Bifunctionalized Marine Sphingoids, Act as Modulators of TRPA1 and TRPM8 Channels
2012
Propensity Score Matching and Subclassification in Observational Studies with Multi-Level Treatments
2016 StandoutNobel
Discovery, Optimization, and Biological Evaluation of 5-(2-(Trifluoromethyl)phenyl)indazoles as a Novel Class of Transient Receptor Potential A1 (TRPA1) Antagonists
2014 StandoutNobel
Marine natural products
2015 Standout
Cannabinomimetic Lipid from a Marine Cyanobacterium
2011
A double‐blind, randomized, placebo‐controlled, parallel group study of THC /CBD spray in peripheral neuropathic pain treatment
2014
The Female Athlete Triad
2007
Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
2018
Cannabinoids for Medical Use
2015 Standout
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa)
2011
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
A Review of Natural Fibers Used in Biocomposites: Plant, Animal and Regenerated Cellulose Fibers
2015 Standout
Structural insights into TRPM8 inhibition and desensitization
2019 StandoutScienceNobel
Works of Colin Stott being referenced
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
2013
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
2012
Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
2008
Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
2010
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
2011
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
2013
Changes in bone mineral density, body composition and biochemical markers of bone turnover during weight gain in adolescents with severe anorexia nervosa: a 1-year prospective study
2005
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
2012
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
2016
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis
2012
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
2010
A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
2011
Cannabinoids for the pharmaceutical industry
2004